[HTML][HTML] Downregulation of SNCA expression by targeted editing of DNA methylation: a potential strategy for precision therapy in PD
B Kantor, L Tagliafierro, J Gu, ME Zamora, E Ilich… - Molecular therapy, 2018 - cell.com
Elevated levels of SNCA have been implicated in the pathogenesis of Parkinson's disease
(PD), while normal physiological levels of SNCA are needed to maintain neuronal function …
(PD), while normal physiological levels of SNCA are needed to maintain neuronal function …
[引用][C] Downregulation of SNCA Expression by Targeted Editing of DNA Methylation: A Potential Strategy for Precision Therapy in PD
B Kantor, L Tagliafierro, J Gu, ME Zamora, E Ilich… - Molecular …, 2018 - cir.nii.ac.jp
Downregulation of SNCA Expression by Targeted Editing of DNA Methylation: A Potential
Strategy for Precision Therapy in PD | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
Strategy for Precision Therapy in PD | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
[HTML][HTML] Downregulation of SNCA Expression by Targeted Editing of DNA Methylation: A Potential Strategy for Precision Therapy in PD
B Kantor, L Tagliafierro, J Gu, ME Zamora… - Molecular …, 2018 - ncbi.nlm.nih.gov
Elevated levels of SNCA have been implicated in the pathogenesis of Parkinson's disease
(PD), while normal physiological levels of SNCA are needed to maintain neuronal function …
(PD), while normal physiological levels of SNCA are needed to maintain neuronal function …
[PDF][PDF] Downregulation of SNCA Expression by Targeted Editing of DNA Methylation: A Potential Strategy for Precision Therapy in PD
B Kantor, L Tagliafierro, J Gu, ME Zamora, E Ilich… - Molecular …, 2018 - academia.edu
Elevated levels of SNCA have been implicated in the pathogenesis of ParkinsonLs disease
(PD), while normal physiological levels of SNCA are needed to maintain neuronal function …
(PD), while normal physiological levels of SNCA are needed to maintain neuronal function …
Downregulation of SNCA Expression by Targeted Editing of DNA Methylation: A Potential Strategy for Precision Therapy in PD.
B Kantor, L Tagliafierro, J Gu, ME Zamora… - … Therapy: the Journal …, 2018 - europepmc.org
Elevated levels of SNCA have been implicated in the pathogenesis of Parkinson's disease
(PD), while normal physiological levels of SNCA are needed to maintain neuronal function …
(PD), while normal physiological levels of SNCA are needed to maintain neuronal function …
[HTML][HTML] Downregulation of SNCA Expression by Targeted Editing of DNA Methylation: A Potential Strategy for Precision Therapy in PD
B Kantor, L Tagliafierro, J Gu, ME Zamora, E Ilich… - Molecular Therapy, 2018 - Elsevier
Elevated levels of SNCA have been implicated in the pathogenesis of Parkinson's disease
(PD), while normal physiological levels of SNCA are needed to maintain neuronal function …
(PD), while normal physiological levels of SNCA are needed to maintain neuronal function …
Downregulation of SNCA Expression by Targeted Editing of DNA Methylation: A Potential Strategy for Precision Therapy in PD
B Kantor, L Tagliafierro, J Gu… - … therapy: the journal …, 2018 - pubmed.ncbi.nlm.nih.gov
Elevated levels of SNCA have been implicated in the pathogenesis of Parkinson's disease
(PD), while normal physiological levels of SNCA are needed to maintain neuronal function …
(PD), while normal physiological levels of SNCA are needed to maintain neuronal function …